By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > Tracking Ruane, Cunniff, & Goldfarb’s Portfolio – Q3 2023 Update (MUTF:SEQUX)
News

Tracking Ruane, Cunniff, & Goldfarb’s Portfolio – Q3 2023 Update (MUTF:SEQUX)

News
Last updated: 2023/12/21 at 12:06 AM
By News
Share
12 Min Read
SHARE

Contents
Stake Increases:Stake Decreases:

This article is part of a series that provides an ongoing analysis of the changes made to Ruane, Cunniff & Goldfarb’s 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 11/14/2023. Please visit our Tracking Ruane, Cunniff & Goldfarb’s Portfolio article for an idea on their investment philosophy and our previous update for the moves during Q2 2023.

This quarter Ruane, Cunniff, & Goldfarb’s 13F portfolio value decreased ~5% from $6.34B to $6.02B. The number of holdings increased from 34 to 36. 15 of those stakes are significantly large (more than ~0.5% of the portfolio each) and they are the focus of this article. The top three positions are at ~30% while the top five are at ~47% of the 13F assets: Alphabet, Intercontinental Exchange, UnitedHealth, Elevance Health, and Liberty Media.

The firm is best known as the investment advisor of the Sequoia Fund No Load (MUTF:SEQUX) which has a venerable ~53-year track record (July 15, 1970, inception, 13.05% annualized return compared to 11.07% for the S&P 500 index). The performance for 2022 was terrible: Negative 30.52% compared to Negative 18.11% for the S&P 500 index. For H1 2023, they again underperformed the S&P 500 Index: 12.91% vs. 16.89%. After new management took over in Q1 2016, the portfolio has seen a significant shift to information & services businesses from asset-intensive manufacturing & retail. Also, the cash allocation which had averaged ~20% since inception is now less than 5%. The following significant stakes in Sequoia’s portfolio are not in the 13F report as they are not 13F securities: Constellation Software Inc. (OTCPK:CNSWF), Eurofins Scientific SE (OTCPK:ERFSF), Lumine Group Inc. (OTCPK:LMGIF), Rolls-Royce Holdings plc (OTCPK:RYCEY), SAP SE (SAP), and Universal Music Group N.V. (OTCPK:UMGNF). Bill Ruane was a Benjamin Graham pupil. To learn about Benjamin Graham’s teachings, check out the classics The Intelligent Investor and Security Analysis.

Stake Increases:

Elevance Health, Inc. (ELV): The 8.31% ELV stake was established in H1 2021 at prices between ~$288 and ~$402. Q2 2022 saw a ~42% reduction in prices between ~$444 and ~$530. That was followed by a ~16% selling during Q4 2022 at prices between ~$454 and ~$547. There was a ~30% stake increase last quarter at prices between ~$436 and ~$496. This quarter also saw a ~10% increase. The stock is now at ~$459.

Formula One Group (FWONK) (LLYVK) (LLYVA): Sequoia’s Q4 2016 letter disclosed a new stake in Liberty Media Formula One. They participated in Liberty’s acquisition of Formula One and acquired the shares at a discounted price of $25. The stake has wavered. FWONK is currently at $64.69. The stake is now at 8.13% of the portfolio. There was a minor ~2% trimming last quarter and a marginal increase this quarter.

Stake Decreases:

Alphabet Inc. (GOOG) (GOOGL): GOOG is now the largest 13F position at 10.71% of the portfolio. It was first purchased in 2008 and that original stake was almost sold out the following year. In 2010, a much larger position was built in the low-teens price range. Recent activity follows: Q2 2019 saw a one-third reduction in prices between ~$52 and ~$64. That was followed with a ~60% reduction over the six quarters through Q4 2020 at prices between ~$53 and ~$107. The last six quarters saw a ~40% reduction in prices between ~$83 and ~$139. The stock currently trades at ~$140.

Intercontinental Exchange, Inc. (ICE): ICE is currently the second largest 13F position at 10.51% of the portfolio. It was purchased in Q3 2020 at prices between ~$92 and ~$107. There was a ~90% stake increase in Q2 2022 at prices between ~$90 and ~$133. The stock currently trades at ~$122. The last five quarters have seen a ~13% trimming.

UnitedHealth Group Incorporated (UNH): UNH is a large (top three) 9.17% of the portfolio stake. It was established in Q4 2019 at prices between $215 and $296 and increased by ~300% next quarter at prices between ~$195 and ~$305. Q3 2020 saw a ~30% stake increase at prices between ~$291 and ~$324. There was a ~25% selling in Q2 2022 at prices between ~$452 and ~$546. That was followed with a ~15% reduction during Q4 2022 at prices between ~$499 and ~$555. The stock currently trades at ~$516. The last three quarters saw only minor adjustments.

The Charles Schwab Corporation (SCHW): SCHW is now at ~8% of the portfolio. It was first purchased in Q2 2016 at a cost-basis of ~$29. Q1 2020 saw a ~40% stake increase at prices between $28.50 and $49. There was a ~17% selling next quarter at prices between $32.50 and $43. The stock is now at $67.12. The last quarter saw a ~9% stake increase while this quarter saw a ~3% trimming.

CarMax, Inc. (KMX): KMX is currently at 6.53% of the 13F portfolio. It was purchased in Q2 2016 at prices between $46 and $56 and increased by ~70% in Q4 2016 at prices between $48.50 and $66. Q4 2017 saw a ~30% selling at prices between $64 and $77 while next quarter there was a ~80% increase at prices between $59 and $72. The eleven quarters through Q4 2020 had seen a ~45% selling at prices between ~$44 and ~$109. The stock is now at $74.68. The last several quarters have also seen trimming.

Jacobs Solutions Inc. (J): J is a 6.49% long-term stake first purchased in 2012. Recent activity follows: Q2 2018 saw a ~20% increase at prices between $56.50 and $67 while the next six quarters saw minor trimming. There was a ~25% selling in Q1 2020 at prices between ~$63 and ~$104. That was followed with a similar reduction in Q2 2021 at prices between ~$129 and ~$143. The stock currently trades at ~$126. The last quarter saw a ~12% increase while this quarter there was a ~3% trimming.

Taiwan Semiconductor Manufacturing Company Limited (TSM): The ~6% of the portfolio TSM stake was purchased in Q4 2019 at prices between $46.50 and $59. There was a ~130% stake increase in Q2 2020 at around the same price range. Q1 2021 saw a ~12% selling while in Q3 2021 there was a ~20% stake increase. Q3 2022 saw a ~30% selling at prices between ~$69 and ~$92. The stock currently trades at ~$100. The last few quarters saw minor trimming.

Liberty Broadband Corporation (LBRDK): LBRDK is a ~6% of the portfolio position purchased in Q1 2018 at prices between $86 and $97 and increased by ~20% next quarter at prices between $69 and $85. Q1 2020 saw a ~18% reduction in prices between ~$91 and ~$139. There was a ~23% stake increase in Q1 2021 at prices between ~$143 and ~$157. The last quarter saw another one-third increase at prices between ~$71 and ~$85. The stock currently trades at $77.39. There was minor trimming this quarter.

Credit Acceptance Corporation (CACC): CACC is a 5.84% stake established in Q1 2017 at prices between $185 and $221. There was a ~25% stake increase in Q4 2020 at prices between $288 and $356. Q3 2021 saw a ~18% selling at prices between ~$438 and ~$670. That was followed with a one-third reduction next quarter at prices between ~$582 and ~$696. The stock is now at ~$510. The last several quarters saw only minor adjustments.

Note: They have a ~5.8% ownership stake in Credit Acceptance Corp.

Capital One Financial Corporation (COF): COF is a 5.32% of the portfolio position established during Q3 2022 at prices between ~$91 and ~$116 and the stock currently trades at ~$128. There was a ~25% stake increase last quarter at prices between ~$86 and ~$114. There was a minor ~3% trimming this quarter.

Meta Platforms, Inc. (META): The 4.45% META position saw a whopping ~600% stake increase in Q1 2018 at prices between $152 and $193. The next two quarters saw another ~27% increase at prices between $155 and $218. Q1 2019 saw an about-turn: ~23% reduction in prices between $124 and $173. Q1 2021 saw a ~13% stake increase at prices between ~$246 and ~$299. Q3 2022 also saw a ~11% stake increase. The last two quarters saw a ~70% selling at prices between ~$125 and ~$289. The stock currently trades at ~$349. There was a ~3% trimming this quarter.

Berkshire Hathaway Inc. (BRK.B) (BRK.A): Berkshire’s stake is now at ~4% of the portfolio. It is a very long-term position that was the largest stake in their first 13F filing in 1999. Recent activity follows: Q1 2018 saw a one-third selling at prices between ~$191 and ~$217. The nine quarters through Q1 2022 had seen the large stake sold down at prices between ~$169 and ~$359. The next quarter saw another one-third selling at prices between ~$268 and ~$353. The stock is now at ~$355. The last five quarters also saw minor trimming.

The spreadsheet below highlights changes to Ruane, Cunniff, & Goldfarb’s 13F stock holdings in Q3 2023:

William J. Ruane - Sequoia Fund - Ruane, Cunniff, & Goldfarb Portfolio - Q3 2023 13F Report Q/Q Comparison

William J. Ruane – Sequoia Fund – Ruane, Cunniff, & Goldfarb Portfolio – Q3 2023 13F Report Q/Q Comparison (John Vincent (author))

Source: John Vincent. Data constructed from Ruane, Cunniff, & Goldfarb’s 13F filings for Q2 2023 and Q3 2023.

Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.

Read the full article here

News December 21, 2023 December 21, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Fortive: The Stock Is In A Show-Me Phase (NYSE:FTV)

By News
News

Black Hills: How Defensive Is Your A Utility? (NYSE:BKH)

By News
News

Touchstone Sands Capital Select Growth Fund Q1 2025 Commentary (TSNAX)

By News
News

Central Puerto: Solid Fundamentals And Limited Room For Growth (NYSE:CEPU)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?